申请人:Arbutus Biopharma Corporation
公开号:EP3950004A1
公开(公告)日:2022-02-09
The invention provides certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, a double stranded siRNA, and optional linking groups. Certain embodiments also provide synthetic methods useful for preparing the conjugates. The conjugates are useful to target therapeutic double stranded siRNA to the liver and to treat liver diseases including hepatitis (e.g. hepatitis B and hepatitis D).
本发明提供了某些核酸(如双链 siRNA 分子)以及由靶向分子、双链 siRNA 和任选连接基团组成的共轭物。某些实施方案还提供了制备共轭物的合成方法。这些共轭物可用于将治疗性双链 siRNA 靶向肝脏并治疗包括肝炎(如乙型肝炎和丁型肝炎)在内的肝脏疾病。